Home>Topics>Companies>Novartis

Novartis NVS

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Vanda Regains Fanapt Rights From Novartis and Receives Equity Infusion; Raising FVE

      Commentary

      Tue, 23 Dec 2014

      rating following its settlement agreement with Novartis , which results in Novartis transferring the U.S. and Canadian rights for ..... schizophrenia drug Fanapt back to Vanda. In addition, Novartis will make a $25 million equity investment in Vanda

    2. Novartis says Alcon's Travatan receives EU approval

      Headlines

      Tue, 23 Dec 2014

      ZURICH, Dec 23 (Reuters) - Swiss pharmaceutical group Novartis said on Tuesday the European Commission had approved an additional treatment for its eyecare unit Alcon's Travatan treatment for glaucoma, a chronic, sight-threatening eye disease.

    3. Lilly must divest Sentinel products after FTC nod on Novartis deal

      Headlines

      Mon, 22 Dec 2014

      WASHINGTON (Reuters) - Eli Lilly and Co has won approval to buy Novartis AG 's animal health unit on condition that it divests its Sentinel line of products for treating heartworm in dogs, the Federal...

    4. Lilly to divest some Sentinel products to win approval on Novartis

      Headlines

      Mon, 22 Dec 2014

      WASHINGTON, Dec 22 (Reuters) - Eli Lilly and Co has won approval to buy Novartis AG 's animal health unit on condition that it divest the Sentinel line of products for treating heartworm in dogs, the...

    5. Morphosys gets payment from Novartis for oncology research

      Headlines

      Mon, 22 Dec 2014

      FRANKFURT, Dec 22 (Reuters) - Morphosys AG on Monday said it had received a payment from Novartis in connection with the initiation of a phase 1 clinical trial of a HuCAL antibody in the field of oncology.

    6. GSK shareholders approve asset swap deal with Novartis

      Headlines

      Thu, 18 Dec 2014

      LONDON, Dec 18 (Reuters) - Shareholders in British drugmaker GlaxoSmithKline have approved a planned deal with Switzerland's Novartis , which will see the two pharmaceutical groups trade more than $20...

    7. Novartis sues India's Cipla over respiratory drug Onbrez

      Headlines

      Wed, 17 Dec 2014

      MUMBAI, Dec 17 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's price.

    8. Novartis buys 12.8 pct stake in BioLineRX in co-development deal

      Headlines

      Tue, 16 Dec 2014

      JERUSALEM, Dec 16 (Reuters) - Swiss drugmaker Novartis AG bought a 12.8 percent stake in Israeli biopharmaceutical company BioLineRX Ltd as part of a multi-year collaboration deal, BioLineRX said on Tuesday.

    9. FDA approves Novartis' Signifor drug for rare hormonal disorder

      Headlines

      Tue, 16 Dec 2014

      ZURICH, Dec 16 (Reuters) - U.S. health regulators have approved Novartis ' drug Signifor LAR as a treatment for a rare and life-threatening hormonal disorder, the Swiss drugmaker said on Tuesday.

    10. Ultimate Stock-Pickers: Top Holdings of Top-Performing Managers

      Headlines

      Tue, 16 Dec 2014

      Adobe ADBE 2 Wide 76.02 1.17 Medium 41,328 3.8 Novartis NVS 3 Wide 93.52 0.98 Low 224,259 2.8 SW Air LUV ..... most recent period, selling 1.3 million shares of Novartis NVS "> NVS during the third quarter. This did little to

    « Prev12345Next »
    Content Partners